This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, J.
Right arrow Articles by Koide, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, J.
Right arrow Articles by Koide, H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2000, p. 4658-4665, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Involvement of Ras and Ral in Chemotactic Migration of Skeletal Myoblasts

Jotaro Suzuki, Yuji Yamazaki, Li Guang, Yoshito Kaziro, and Hiroshi Koide*

Faculty of Bioscience and Biotechnology, Tokyo Institute of Technology, Midori-ku, Yokohama 226-8501, Japan

Received 10 January 2000/Returned for modification 7 March 2000/Accepted 13 April 2000


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In skeletal myoblasts, Ras has been considered to be a strong inhibitor of myogenesis. Here, we demonstrate that Ras is involved also in the chemotactic response of skeletal myoblasts. Expression of a dominant-negative mutant of Ras inhibited chemotaxis of C2C12 myoblasts in response to basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), and insulin-like growth factor 1 (IGF-1), key regulators of limb muscle development and skeletal muscle regeneration. A dominant-negative Ral also decreased chemotactic migration by these growth factors, while inhibitors for phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase (MEK) showed no effect. Activation of the Ras-Ral pathway by expression of an activated mutant of either Ras, the guanine-nucleotide dissociation stimulator for Ral, or Ral resulted in increased motility of myoblasts. The ability of Ral to stimulate motility was reduced by introduction of a mutation which prevents binding to Ral-binding protein 1 or phospholipase D. These results suggest that the Ras-Ral pathway is essential for the migration of myoblasts. Furthermore, we found that Ras and Ral are activated in C2C12 cells by bFGF, HGF and IGF-1 and that the Ral activation is regulated by the Ras- and the intracellular Ca2+-mediated pathways. Taken together, our data indicate that Ras and Ral regulate the chemotactic migration of skeletal muscle progenitors.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Migration of skeletal muscle precursor cells is a crucial step in skeletal muscle development and postlesional muscle regeneration. In vertebrate limb development, myogenic precursor cells actively migrate from the lateral lip of the dermomyotome into the limb buds, where they terminally differentiate (7, 48, 55). During migration, cells are prevented from myogenic differentiation (1, 27, 63). These processes seem to be governed by a diverse array of signaling factors that are secreted from adjacent tissues, including the limb buds (6, 15, 36). An initial determination of migratory limb muscle precursors is thought to be achieved by upregulation of several transcription factors such as Pax-3 (3). Pax-3 induces the expression of c-Met, a tyrosine kinase receptor for hepatocyte growth factor (HGF) (also known as scatter factor), leading to HGF-guided migration of myogenic precursor cells from the dermomyotome into the limb buds (5, 8, 23, 38). Fibroblast growth factors (FGFs), which regulate outgrowth and patterning of limbs (44, 52), act as chemoattractants for several kinds of limb bud cells, including myogenic precursor cells (4, 42, 72). Thus, HGF and FGFs are likely to induce the movement of myogenic precursors for the patternings of limb skeletal muscle. Besides HGF and FGFs, insulin-like growth factor 1 (IGF-1) has been suggested to be involved in limb muscle formation (12-14), although it is unknown whether IGF-1 can act as a chemoattractant. These three factors also seem to be involved in postlesional regeneration of skeletal muscle, which requires the migration of skeletal muscle satellite cells (9, 16, 19, 25, 28, 40, 41, 43, 71).

Ras (H-, K-, or N-Ras) is one of a number of small GTP-binding proteins that function as molecular switches by cycling between active GTP- and inactive GDP-bound states (32). The ratio of the two states is regulated positively by guanine-nucleotide exchange factors (GEFs) and negatively by GTPase-activating proteins (GAPs). A variety of growth factors coupled to receptor tyrosine kinases induce Ras activation. Ras activates multiple effectors, including Raf (i.e., A-Raf, B-Raf, and Raf-1), Ral GEF (i.e., RalGDS, Rlf, and Rgl), and phosphatidylinositol 3-kinase (PI3K) (69, 75), and plays an important role in several cellular processes, such as proliferation and differentiation.

Recent reports suggest the involvement of Ras in cell motility. For instance, cell migration in wound healing, FGF-stimulated motility of endothelial cells, platelet-derived growth factor-stimulated chemotaxis of fibroblasts, and HGF-induced scattering of epithelial cells are dependent on Ras activity (17, 22, 34, 60, 62). A Dictyostelium mutant lacking Ras GEF or a subtype of Ras has been reported to have a defect in cell movement (26, 68). The Caenorhabditis elegans ras homologue, let-60, mediates a gonadal signal required for the migration of sex myoblasts (65). For Drosophila melanogaster, expression of a dominant-negative Ras mutant inhibits the migration of the border cells during oogenesis (39). In addition, an activated mutant of Ras partially substitutes for breathless, a Drosophila FGF receptor homologue, in the migration of tracheal cells (59). Thus, Ras seems to function as a crucial regulator of cell motility. However, Ras involvement in migration of mammalian skeletal muscle cells has not been investigated. In this study, to examine the role of Ras in the migratory response of skeletal muscle precursors, we utilized C2C12 myoblasts (78) as an in vitro model system, since it has been demonstrated that, when implanted into mouse muscles, C2C12 cells can migrate toward areas of muscle injury and regeneration to form myofibers (71). Here, we demonstrate that Ras and its downstream molecule, Ral, are involved in the regulation of myogenic cell migration.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Plasmids. Complementary DNA of raf-1 was kindly provided by Martin McMahon (University of California, San Francisco). The expression plasmids pBJ/Myc-RalGDS-CAAX and pBJ/Myc-RalBP1 were generous gifts from Akira Kikuchi (Hiroshima University, Hiroshima, Japan). Plasmids pOPRSV1-H-rasG12V and pOPRSV1-H-rasS17N were constructed as described elsewhere (66). To construct pOPRSV1-ralAS28N, the fragment carrying FLAG-His6-tagged ralAS28N was inserted into pOPRSV1-CAT (Stratagene, La Jolla, Calif.). The DNA fragments of the Ras-binding domain (RasBD) of Raf-1 (amino acids 51 to 131) and the Ral-binding domain (RalBD) of Ral-binding protein 1 (RalBP1) (amino acids 397 to 518) were generated by PCR and inserted into pGEX-2T to produce pGEX-RasBD and pGEX-RalBD, respectively. The fragments of H-rasG12V,E37G, ralG23V, ralG23V,D49N, and ralG23V,Delta N were generated by site-directed mutagenesis from H-rasG12V or the wild-type ralA and subcloned into pCMV5 (2).

Reagents. We purchased anti-H-Ras antibody (sc-520) from Santa Cruz Biotechnology (Santa Cruz, Calif.), anti-Myc (9E10) antibody from BabCO (Richmond, Calif.), anti-active mitogen-activated protein kinase (MAPK) antibody (V8031) and U0126 from Promega Corporation (Madison, Wis.), anti-RalA antibody (R23520) and anti-Ras antibody (R02120) from Transduction Laboratories (Lexington, Ky.), human IGF-1 from Life Technologies (Rockville, Md.), human basic FGF (bFGF) from Pepro Tech EC (London, England), HGF from Becton Dickinson Labware (Bedford, Mass.), A23187 and LY294002 from Calbiochem (San Diego, Calif.), and 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM) from Dojindo (Kumamoto, Japan).

Cell culture and transfection. C2C12 cells were obtained from RIKEN Cell Bank (Ibaraki, Japan). C2C12 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 15% (vol/vol) fetal bovine serum. For stable transfection, pOPRSV1-H-rasG12V, -H-rasS17N, or -ralAS28N was introduced into C2C12 cells with p3'SS (Stratagene) by using Lipofectamine (Life Technologies). One day after transfection, transfectants were isolated in the culture medium containing 400 µg of G418 per ml and 200 µg of hygromycin per ml. For transient transfection, plasmids of interest (2.5 µg) were introduced into subconfluent C2C12 cells in a 60-mm dish with Lipofectamine and Lipofectamine Plus (Life Technologies).

Human normal skeletal muscle cells were obtained from BioWhittaker (Walkersville, Md.) and were cultured in skeletal muscle basal medium (BioWhittaker) supplemented with 10 ng of epidermal growth factor per ml, 100 ng of insulin per ml, 500 µg of feutin per ml, 39 µg of dexamethasone per ml, and antibiotics.

Preparation of cell lysate. Harvested cells were lysed in lysis buffer (20 mM HEPES-NaOH [pH 7.2], 150 mM NaCl, 10% [vol/vol] glycerol, 0.5% [vol/vol] Triton X-100, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 10 mM NaF, 1 mM Na3VO4, 25 mM beta -glycerophosphate, 2 µg of aprotinin per ml, 1 µg of leupeptin per ml, and 1 µg of pepstatin A per ml). After centrifugation at 12,000 × g, the supernatant was saved as cell lysate. The protein concentration of the cell lysate was determined using protein assay CBB solution (Nakalai Tesque, Kyoto, Japan).

Pull-down assay. Cell lysates (500 µg of protein) were incubated for 40 min at 4°C with 20 µl of glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech, Uppsala, Sweden) and 10 µg of glutathione S-transferase (GST)-RasBD or GST-RalBD that had been produced in Escherichia coli and purified according to the procedure recommended by the manufacturer. Then the beads were washed three times with 20 mM HEPES-NaOH (pH 7.4)-150 mM NaCl-0.25% (vol/vol) Triton X-100-5 mM MgCl2 and boiled in the sample buffer. Samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (15% acrylamide), followed by Western blotting analysis using anti-Ras or anti-RalA antibody.

Migration assay and motility assay. Prior to the experiments, Falcon cell culture inserts (Becton Dickinson Labware) were coated with 10 µg of E-C-L Cell Attachment Matrix (Upstate Biotechnology) per ml. Trypsinized cells were washed once with the culture medium and suspended in DMEM containing 0.1% bovine serum albumin (BSA) at a concentration of 1 × 105 cell/ml. DMEM containing 0.1% BSA (750 µl) was added to a Falcon companion plate (24 wells; Becton Dickinson Labware). In the migration assay, growth factors were also added to the companion plate. Immediately after the cell culture inserts were placed on the companion plate, the cell suspensions (500 µl) were added to the inserts. Samples were then incubated for 2 h at 37°C in a 10% CO2 atmosphere. After incubation, the nonmigrated cells were wiped away from the upper surface of the membrane of the insert, and the migrated cells on the lower surface of the membrane were stained with Diff-Quik (International Reagents Corp., Kobe, Japan). The number of stained cells was counted in five microscope fields.

Adhesion assay. Trypsinized cells were washed once and suspended in DMEM containing 0.1% BSA at a concentration of 5 × 105 cells/ml. The cell suspensions (100 µl) were added to a 96-well dish which was precoated with 10 µg of E-C-L Cell Attachment Matrix per ml. After 30 min of incubation at 37°C in a 10% CO2 atmosphere, the suspensions were aspirated and the wells were washed three times with phosphate-buffered saline. Then, adherent cells were stained with 0.1% (wt/vol) crystal violet in 20% (vol/vol) methanol for 5 min at room temperature. The stain was eluted with 100 µl of 50% (vol/vol) ethanol, and the absorbance at 595 nm was measured.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Chemotactic response of C2C12 myoblasts to growth factors. In order to study the chemotactic behavior of C2C12 myoblasts in response to growth factors, we performed an in vitro migration assay with the multiwell chemotaxis chamber. In this assay, cells in an upper chamber migrate through an extracellular matrix protein (ECM)-coated nucleopore filter to a lower chamber, which includes a higher concentration of chemotactic factors. In preliminary experiments, we observed that C2C12 myoblasts migrated to bFGF, HGF, IGF-1, and platelet-derived growth factor but that they migrated hardly at all to transforming growth factor-beta , interleukin-15, or bone morphogenetic protein-4 (data not shown). For further studies, we selected bFGF, HGF, and IGF-1, whose involvement in skeletal muscle development and regeneration had been indicated. As shown in Fig. 1A, bFGF, HGF, and IGF-1 significantly stimulated migration of C2C12 myoblasts. Among them, IGF-1 showed the highest chemotactic activity toward C2C12 cells. We carried out a checkerboard analysis (79) and confirmed that the observed migratory response is mainly chemotaxis, a directional migration along a gradient of factors (data not shown). Since IGF-1 has not been reported to be a chemoattractant for myoblasts, we confirmed our results using primary skeletal muscle satellite cells, skeletal muscle progenitors in adult myofibers (63). Consequently, satellite cells also showed the capability to migrate toward all the growth factors (Fig. 1B). As in the case of C2C12 myoblasts, the highest chemotactic activity was observed for IGF-1. The results suggest that IGF-1, as well as bFGF and HGF, is a chemotactic factor for skeletal muscle precursors.


View larger version (14K):
[in this window]
[in a new window]
  		FIG. 1.   Chemotaxis of C2C12 myoblasts and primary skeletal muscle satellite cells in response to bFGF, HGF, and IGF-1. A migration assay (as described in Materials and Methods) was performed to determine chemotactic migration of C2C12 cells (A) and human satellite cells (B). The concentrations of the growth factors bFGF, HGF, and IGF-1 were 10, 15, and 10 ng/ml, respectively. The data are expressed as the fold increase in the number of migrated cells relative to the number of migrated cells in the absence of factor and are the means ± the standard errors (SE) of at least three independent experiments.

Ras and Ral are involved in chemotaxis of myoblasts. To test the possible involvement of Ras in the chemotactic migration of myoblasts, we established several C2C12 clones that express a dominant-negative mutant of H-Ras (RasS17N) in an isopropyl-beta -D-thiogalactoside (IPTG)-dependent manner. One of these clones, designated C2-RasS17N, was used for further analyses, since this clone expresses RasS17N in excess of endogenous Ras in the presence of IPTG (Fig. 2). After induction of RasS17N, a migration assay was performed for bFGF, HGF, and IGF-1. Expression of RasS17N significantly inhibited migration of myoblasts in response to all factors (Table 1). Since cell adhesiveness toward ECM was not affected by RasS17N expression (Fig. 3A), the inhibition of migration by RasS17N was not due to the reduction of initial attachment of cells to the ECM-coated filters. Therefore, it is suggested that Ras is required for the migration of C2C12 myoblasts in response to bFGF, HGF, and IGF-1.


View larger version (20K):
[in this window]
[in a new window]
  		FIG. 2.   IPTG-induced expression of RasS17N and RalS28N in C2C12 myoblasts. C2-RasS17N and C2-RalS28N cells were cultured for 1 day in the presence (+) or absence (-) of IPTG (5 mM). Then the cells were lysed, and the lysates (25 µg of protein) were subjected to Western blotting analysis with anti-H-Ras and anti-RalA antibodies to detect RasS17N and RalS28N, respectively.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Effect of RasS17N, RalS28N, MEK inhibitor, or PI3K inhibitor on migration of C2C12 myoblasts in response to bFGF, HGF, and IGF-1



View larger version (14K):
[in this window]
[in a new window]
  		FIG. 3.   Expression of RasS17N or RalS28N does not affect cell adhesion. C2-RasS17N (A) and C2-RalS28N (B) cells were cultured for 1 day in the presence (+) or absence (-) of IPTG (5 mM). Then a cell adhesion assay was performed as described in Materials and Methods. The cell number obtained in the absence of IPTG was set to 100%. Results are the means ± the SE of at least three experiments.

Ras is known to activate at least three pathways, the Raf-mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK), the PI3K-Akt, and the Ral GEF-Ral pathways. To examine the involvement of Raf- and PI3K-exerted signaling pathways in the chemotaxis of C2C12 cells, we utilized specific inhibitors for MEK (U0126) and PI3K (LY294002). Neither 10 µM U0126 nor 10 µM LY294002 exhibited a substantial effect on the chemotactic migration of C2C12 cells (Table 1). We confirmed that, at these concentrations, the inhibitors could abolish IGF-1-induced phosphorylation of ERK and Akt even after a 2-h treatment of cells, suggesting that the activity of ERK and Akt was suppressed throughout the migration assay (data not shown). Therefore, the Raf-ERK and the PI3K-Akt pathways may not be essential for C2C12 migration toward bFGF, HGF, and IGF-1. We next determined whether the Ral GEF-Ral pathway is involved in the chemotactic response. For this purpose, we generated a C2C12 clone (C2-RalS28N) that inducibly expresses a dominant-negative RalA (RalS28N) (Fig. 2). As shown in Table 1, overexpression of RalS28N reduced chemotactic migration by bFGF, HGF, and IGF-1. Cell adhesion onto ECM was not affected by RalS28N expression (Fig. 3B). These results suggest that activation of the Ral GEF-Ral pathway downstream of Ras is essential for the chemotactic migration of C2C12 myoblasts.

Activation of Ras and Ral stimulates motility of myoblasts. We investigated whether activation of the Ras-Ral GEF-Ral pathway stimulates motility of C2C12 myoblasts. First, we examined the effect of an activated mutant of H-Ras (RasG12V) on cell motility. When RasG12V was transiently expressed in C2C12 cells, transfected cells showed higher motility (Fig. 4A), suggesting that Ras activation leads to an increase of cell motility in C2C12 cells. Second, we tested the ability of Ral GEF to stimulate the motility of C2C12 cells. For this, we used two mutants: RasG12V,E37G, an effector-domain mutant of Ras that is capable of activating Ral GEFs but not Raf and PI3K (74), and RalGDS-CAAX, an activated mutant of RalGDS (45). When these mutants were transiently expressed in C2C12, both transfected myoblasts displayed higher motility than the mock transfectant (Fig. 4B and C). Finally, we examined the effect of a constitutively activated RalA (RalG23V) and found that transient expression of RalG23V in C2C12 myoblasts also stimulated cell motility (Fig. 4D). These data suggest that activation of the Ras-Ral GEF-Ral pathway can increase the motility of C2C12 cells.


View larger version (11K):
[in this window]
[in a new window]
  		FIG. 4.   Activation of the Ras-Ral GEF-Ral pathway stimulates cell motility. C2C12 cells were transfected with pOPRSV1-H-RasG12V (A), pCMV5-rasG12V,E37G (B), pBJ-Myc/RalGDS-CAAX (C), or pCMV5-ralG23V, -ralG23V,D49N, or -ralG23V,Delta N (D) and subjected to migration assay. The values are expressed as the fold increase in the number of the migrated cells and are the means ± the SE of three independent experiments. As shown at the bottom of each panel, expression of each protein was confirmed by Western blotting analysis using anti-H-Ras (for panels A and B), anti-Myc (for panel C), and anti-RalA (for panel D) antibodies.

It was reported that Ral binds to its effector molecules, RalBP1 (also known as RLIP76, RIP1, or cytocentrin) (10, 31, 56, 58) and phospholipase D (PLD) (29), through the effector region and the amino-terminal 11 amino acids, respectively. Thus, we examined whether these two molecules are involved in cell motility using two Ral mutants: RalG23V,S49N, an effector region mutant of Ral lacking affinity to RalBP1 (10); and RalG23V,Delta N, which cannot bind to PLD due to a deletion of the amino-terminal 11 amino acids (29). Consequently, C2C12 myoblasts expressing either of the above two Ral mutants exhibited much lower motility than those expressing RalG23V (Fig. 4D). Therefore, it is possible that both RalBP1 and PLD are involved in Ral-mediated cell migration.

Ras and Ral are activated by chemotactic signals. In order to investigate whether Ras and Ral are indeed activated in C2C12 cells during chemotactic migration, we performed a pull-down assay to measure the number of the GTP-bound forms of Ras and Ral within C2C12 cells. Figure 5 shows that Ras-GTP and Ral-GTP accumulated in C2C12 cells in response to bFGF, HGF, and IGF-1, suggesting that Ras and Ral are activated by these factors. However, the extents of Ral activation by these three factors were not parallel to those of Ras activation. Activation of Ras was strongly stimulated by bFGF but stimulated only moderately by HGF and IGF-1. On the other hand, IGF-1 showed the highest activity for Ral activation. These data raise the possibility that Ral may be activated, in part, in a Ras-independent manner.


View larger version (35K):
[in this window]
[in a new window]
  		FIG. 5.   Basic FGF, HGF, and IGF-1 induce activation of Ras and Ral. C2C12 cells were starved for 2.5 h in DMEM containing 0.1% BSA and stimulated by bFGF (50 ng/ml), HGF (50 ng/ml), or IGF-1 (50 ng/ml) for 6 min at 37°C. Then cells were lysed, and the amounts of Ras-GTP or Ral-GTP in the lysates were determined by pull-down assay, as described in Materials and Methods.

We thus examined whether Ral activation by the growth factors is mediated by Ras in C2C12 myoblasts. IGF-1 was chosen for this analysis since it possesses the greatest ability to stimulate the Ral activation, as well as the migration of C2C12 cells, among the three factors. In C2-RasS17N cells, IPTG-induced expression of RasS17N inhibited Ral activation by IGF-1, though only partially (Fig. 6A). Western blotting analysis confirmed that RasS17N expression did not affect the amount of endogenous Ral (Fig. 6A). The inhibition was not due to the downregulation of IGF-1 receptor by RasS17N, since the expression of IGF-1 receptor and the IGF-1-induced tyrosine phosphorylation of IGF-1 receptor were not affected by IPTG treatment (data not shown). Therefore, the results suggest that IGF-1-induced activation of Ral is mediated by Ras. The reason for the partial inhibition by RasS17N was not insufficient expression of this dominant-negative mutant, because IPTG treatment of C2-RasS17N cells inhibited almost completely the IGF-1-induced phosphorylation of ERK (Fig. 6A). Thus, our data suggest that there is a Ras-independent pathway, as well as the Ras-dependent pathway, downstream of the IGF-1 receptor for Ral activation.


View larger version (19K):
[in this window]
[in a new window]
  		FIG. 6.   IGF-1 activates Ral through Ras- and Ca2+-dependent pathways. (A) Dominant-negative Ras inhibits IGF-1-induced Ral activation. C2-RasS17N cells were cultured in the presence (+) or absence (-) of IPTG (5 mM) for 1 day and starved for 2.5 h. Cells were stimulated with IGF-1 (50 ng/ml), and the activity of Ral and the phosphorylation of ERK were determined by pull-down assay and by immunoblotting with anti-active MAPK antibody, respectively. The amount of endogenous RalA was verified using anti-RalA antibody. (B) Ral activation by IGF-1 is inhibited by deprivation of intracellular Ca2+. After starvation for 2.5 h, C2C12 cells were treated with BAPTA-AM (25 µM) for 15 min at 37°C. Then cells were stimulated with IGF-1 (50 ng/ml), and the activities of Ral (top) and Ras (bottom) were measured. (C) RasG12V and Ca2+ ionophore cooperatively activate Ral. C2-RasG12V cells were cultured in the presence of IPTG (5 mM) for 16 h. After starvation, cells were incubated with A23187 (500 nM) for 2.5 min, and the amount of Ral-GTP in cell lysates was determined. Relative density of the spots of Ral-GTP on the film was quantitated by the NIH Image program. (Bottom) The amount of endogenous RalA was verified using anti-RalA antibody. Results are representative of at least three independent experiments.

It has been reported that an increase in intracellular Ca2+ leads to Ral activation through a Ras-independent pathway (24, 49, 76, 80). Since IGF-1 induces the increase of intracellular Ca2+ in C2C12 cells (data not shown), we explored the possibility that Ral activation by IGF-1 is mediated by Ca2+. When cells were treated with an intracellular Ca2+ chelator, BAPTA-AM, Ral activation by IGF-1 was partially suppressed (Fig. 6B). The suppression was not through the inhibition of Ras activation, since BAPTA-AM treatment conversely augmented IGF-1-induced Ras activation (Fig. 6B, bottom). The results suggest that the IGF-1-induced Ral activation is mediated also by Ca2+ increase.

Based on the present data, it seems that IGF-1 activates Ral through at least two pathways: the Ras-dependent pathway and the Ca2+-dependent pathway. To confirm this, we investigated the effect of the activated mutant of Ras and a Ca2+ ionophore, A23187, on Ral activation. In C2-RasG12V cells, which express RasG12V in an IPTG-dependent manner (data not shown), either RasG12V or A23187 alone induced Ral activation slightly, whereas the combination of two stimuli resulted in a significant activation of Ral (Fig. 6C). We confirmed that the amount of endogenous Ral was not affected by the expression of RasG12V (Fig. 6C) and that A23187 treatment showed no effect on the basal activity of Ras (data not shown). Therefore, it is likely that Ras and intracellular Ca2+ act coordinately in the activation of Ral by IGF-1.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In this study, we identified IGF-1 as a new chemoattractant for myoblasts. The dominant-negative mutants of Ras and Ral inhibited chemotaxis of C2C12 cells in response to bFGF, HGF, and IGF-1, and activation of the Ras-Ral GEF-Ral pathway stimulated myoblast motility. All three growth factors induced activation of Ras and Ral. These results indicate that Ras and Ral are involved in the migration of skeletal muscle precursor cells towards bFGF, HGF, and IGF-1.

Previously, the role of Ras in cell migration was studied with epithelial cells. As is the case with myoblasts, Ras is required for the locomotion of epithelial cells by HGF (22, 60). However, the signaling pathways downstream of Ras for chemotaxis seem different between myoblasts and epithelial cells. Epithelial cells require activation of PI3K and ERK for HGF-stimulated migration (33, 57, 61). On the other hand, inhibitors for PI3K and MEK had little effect on the chemotactic migration of C2C12 cells (Table 1). Furthermore, a combination of two inhibitors did not further inhibit the migration of C2C12 cells expressing the dominant-negative Ral (J. Suzuki, Y. Kaziro, and H. Koide, unpublished data). These results suggest that, although PI3K and ERK may somehow be involved in chemotactic response of C2C12 cells, their contribution is not as large as that of Ral and that the signaling pathways for the Ras-mediated migration vary among cell types.

Here, we demonstrated that the dominant-negative mutant of Ral inhibits the chemotactic migration of C2C12 cells and that ectopic expression of RalG23V stimulates motility in the absence of chemotactic factors. Furthermore, the profile of Ral activation by FGF, HGF, and IGF-1 corresponded well to the ability of these factors to induce myoblast migration. These results strongly indicate that Ral is involved in the chemotactic migration of mammalian myoblast cells. Since Ral has been implicated in border cell migration during Drosophila oogenesis (39), Ral involvement in cell motility may be evolutionally preserved. The present data also suggest the possibility that Ral may participate in the chemotaxis of other cell types, such as lymphocytes, since Ral is activated by chemoattractants for lymphocytes, such as formyl Met-Leu-Phe, platelet-activating factor, and lysophosphatidic acid (24, 49, 76, 77).

The mechanism underlying the Ral-stimulated motility of myoblasts is presently unknown. Thus far, three types of putative effectors for Ral have been identified: RalBP1, PLD, and filamin (10, 29, 31, 51, 56, 58). Experiments with the Ral mutants suggest that RalBP1 and PLD are possibly involved in motility. RalBP1 has the GAP domain for Rac1 and Cdc42, well-known regulators of the actin cytoskeleton (10, 31, 56), and PLD activation results in actin stress fiber formation (11). Accordingly, to stimulate the cell motility of C2C12 cells, Ral may modulate actin cytoskeleton dynamics by controlling the activities of RalBP1 and PLD. On the other hand, a recent paper suggests that RalBP1 regulates endocytosis of epidermal growth factor and insulin receptors (50). Endocytosis is an essential process in cell motility, since recycling of integrins, receptors for ECM, from the rear of the cell to its leading edge requires endocytosis of integrins at the rear end (37). PLD is also known to be involved in membrane trafficking and vesicle transport (30). Therefore, it is also possible that Ral may stimulate cell motility by recycling membrane proteins, including integrins. As for filamin, its involvement in the Ral-dependent cell movement is unknown. However, since filamin is a downstream intermediate in Cdc42-mediated filopodia formation (51), Ral may also utilize filamin for cell migration.

We showed that IGF-1 utilizes both the Ras- and the Ca2+-mediated pathways for the regulation of Ral activity. Since HGF and bFGF are reported to induce the increase of intracellular Ca2+ (46, 47, 67), these growth factors may activate Ral through the Ras- and the Ca2+-dependent pathways. The use of the Ca2+-dependent pathway, in addition to the Ras-dependent pathway, for Ral activation may be the reason why the level of Ral activation by the growth factors does not correlate to Ras activation. We speculate that the biological significance of the differential activation between Ras and Ral is that, besides the regulation of cell motility through Ral, Ras plays extra roles in migrating myoblasts through the other effectors. For example, bFGF, which only slightly activates Ral in spite of a marked activation of Ras (Fig. 5), strongly inhibits skeletal muscle differentiation (54; Suzuki et al., unpublished data). Since Ras is a strong inhibitor of myogenic differentiation (53), it is possible that bFGF activates Ras not only to increase cell motility but also to inhibit myogenesis.

Several mechanisms of Ca2+-dependent Ral activation have been suggested. It has been reported that Rap1 activation is rapidly induced by the increase of Ca2+ concentration (18, 76). Since Rap1 can activate Ral GEF in a certain type of cell (80), it is possible that Ca2+-mediated activation of Rap1 leads to the activation of Ral in C2C12 cells. Alternatively, it is also possible that Ral is activated by interaction with Ca2+-calmodulin, although Ca2+-calmodulin is a less effective GEF for Ral than Ral GEFs are (70).

IGF-1-induced Ras activation was found to be effectively promoted by BAPTA-AM treatment (Fig. 6B). Furthermore, it was also found that the addition of BAPTA-AM to C2C12 cells by itself can induce Ras activation (Suzuki et al., unpublished data). The precise reason for the observed activation of Ras in the presence of BAPTA-AM is presently unknown. However, since Ras GAPs possess the Ca2+-dependent phospholipid-binding domain (20), it is possible that BAPTA-AM treatment might interfere with the activities of Ras GAPs.

We demonstrated that bFGF, HGF, and IGF-1 act as chemotactic factors for C2C12 cells and primary human muscle satellite cells. It has been reported that FGFs and HGF act as chemoattractants for myoblasts in vivo. Expression of FGFs is observed in the limb buds, including the apical ectodermal ridge and the underlying mesenchyme (44), and interaction between FGFs and their receptors is important for myogenic cell migration from somites to limb buds (27). Expression of HGF is observed in the limb bud along the migrating routes of myogenic progenitors (5). Furthermore, c-met-deficient mice show a defect in migration of myogenic progenitors into the limb buds, which causes complete loss of skeletal muscle of the limb (5). Thus, it is likely that FGFs and HGF are guide molecules for skeletal muscle precursor cells from the dermomyotome to the limb buds (38, 72). Unlike bFGF and HGF, IGF-1 has not been shown to be a chemoattractant for myoblasts, and the biological significance of IGF-1-stimulated myoblast migration is unknown. It has been reported that, like FGFs, IGF-1 is expressed in the apical ectodermal ridge and the underlying mesenchyme (13, 21, 64). In addition, IGF-1 is required for FGFs to promote limb bud outgrowth (12). Therefore, IGF-1 may induce distal migration of myogenic cells in the limb buds during skeletal muscle development. Another possibility is that IGF-1-induced migration may be involved in the postlesional regeneration of skeletal muscle. In injured skeletal muscle, several growth factors, including IGF-1, are locally produced by regenerating muscle cells and inflammatory cells to regulate proliferation and differentiation of satellite cells (9, 16, 19, 25, 28, 40, 41, 43). Thus, IGF-1 may attract satellite cells into muscle regenerating areas.


    ACKNOWLEDGMENTS

We are grateful to Kenji Tago for the construction of pGEX-RasBD and to Martin McMahon and Akira Kikuchi for kindly providing the plasmids. We also thank Shin Mizutani, Kaoru Inouye, Koji Terada, Junji Yamauchi, Motoshi Nagao, and all the other members of our laboratory for helpful discussion.

This work was supported by grants 10680666 and 11160204 (to H.K.) from the Ministry of Education, Science, Sports and Culture of Japan and by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation (JST). Our laboratory at Tokyo Institute of Technology is supported by funds donated by Schering-Plough Corporation.


    FOOTNOTES

* Corresponding author. Present address: Department of Stem Cell Regulation, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Phone: 81-3-5449-5738. Fax: 81-3-5449-5450. E-mail: hkoide{at}ims.u-tokyo.ac.jp.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Amthor, H., B. Christ, M. Weil, and K. Patel. 1998. The importance of timing differentiation during limb muscle development. Curr. Biol. 8:642-652[CrossRef][Medline].
2. Andersson, S., D. L. Davis, H. Dahlback, H. Jornvall, and D. W. Russell. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222-8229[Abstract/Free Full Text].
3. Arnold, H. H., and B. Winter. 1998. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8:539-544[CrossRef][Medline].
4. Bischoff, R. 1997. Chemotaxis of skeletal muscle satellite cells. Dev. Dyn. 208:505-515[CrossRef][Medline].
5. Bladt, F., D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768-771[CrossRef][Medline].
6. Blagden, C. S., and S. M. Hughes. 1999. Extrinsic influences on limb muscle organization. Cell Tissue Res. 296:141-150[CrossRef][Medline].
7. Brand-Saberi, B., and B. Christ. 1999. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res. 296:199-212[CrossRef][Medline].
8. Brand-Saberi, B., T. S. Muller, J. Wilting, B. Christ, and C. Birchmeier. 1996. Scatter factor/hepatocyte growth factor (SF/HGF) induces emigration of myogenic cells at interlimb level in vivo. Dev. Biol. 179:303-308[CrossRef][Medline].
9. Cannon, J. G., and B. A. St. Pierre. 1998. Cytokines in exertion-induced skeletal muscle injury. Mol. Cell. Biochem. 179:159-167[CrossRef][Medline].
10. Cantor, S. B., T. Urano, and L. A. Feig. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol. 15:4578-4584[Abstract].
11. Cross, M. J., S. Roberts, A. J. Ridley, M. N. Hodgkin, A. Stewart, L. Claesson-Welsh, and M. J. O. Wakelam. 1996. Stimulation of actin stress fibre formation mediated by activation of phospholipase D. Curr. Biol. 6:588-597[CrossRef][Medline].
12. Dealy, C. N., K. Clarke, and V. Scranton. 1996. Ability of FGFs to promote the outgrowth and proliferation of limb mesoderm is dependent on IGF-I activity. Dev. Dyn. 206:463-469[CrossRef][Medline].
13. Dealy, C. N., and R. A. Kosher. 1995. Studies on insulin-like growth factor-I and insulin in chick limb morphogenesis. Dev. Dyn. 202:67-79[Medline].
14. Dealy, C. N., and R. A. Kosher. 1996. IGF-I and insulin in the acquisition of limb-forming ability by the embryonic lateral plate. Dev. Biol. 177:291-299[CrossRef][Medline].
15. Dietrich, S. 1999. Regulation of hypaxial muscle development. Cell Tissue Res. 296:175-182[CrossRef][Medline].
16. Floss, T., H. H. Arnold, and T. Braun. 1997. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11:2040-2051[Abstract/Free Full Text].
17. Fox, P. L., G. Sa, S. F. Dobrowolski, and D. W. Stacey. 1994. The regulation of endothelial cell motility by p21 ras. Oncogene 9:3519-3526[Medline].
18. Franke, B., J. W. Akkerman, and J. L. Bos. 1997. Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J. 16:252-259[CrossRef][Medline].
19. Gal-Levi, R., Y. Leshem, S. Aoki, T. Nakamura, and O. Halevy. 1998. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochem. Biophys. Acta 1402:39-51[Medline].
20. Gawler, D. J. 1998. Points of convergence between Ca2+ and Ras signalling pathways. Biochem. Biophys. Acta 1448:171-182[Medline].
21. Geduspan, J. S., B. J. Padanilam, and M. Solursh. 1992. Coordinate expression of IGF-I and its receptor during limb outgrowth. Dev. Dyn. 195:67-73[Medline].
22. Hartmann, G., K. M. Weidner, H. Schwarz, and W. Birchmeier. 1994. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J. Cell Biol. 269:21936-21939.
23. Heymann, S., M. Koudrova, H. H. Arnold, M. Köster, and T. Braun. 1996. Regulation and function of SF/HGF during migration of limb muscle precursor cells in chicken. Dev. Biol. 180:566-578[CrossRef][Medline].
24. Hofer, F., R. Berdeaux, and G. S. Martin. 1998. Ras-independent activation of Ral by a Ca2+-dependent pathway. Curr. Biol. 8:839-842[CrossRef][Medline].
25. Husmann, I., L. Soulet, J. Gautron, I. Martelly, and D. Barritault. 1996. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev. 7:249-258[CrossRef][Medline].
26. Insall, R. H., J. Borleis, and P. N. Devreotes. 1996. The aimless RasGEF is required for processing of chemotactic signals through G-protein-coupled receptors in Dictyostelium. Curr. Biol. 6:719-729[CrossRef][Medline].
27. Itoh, N., T. Mima, and T. Mikawa. 1996. Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle. Development 122:291-300[Abstract].
28. Jennische, E., S. Ekberg, and G. L. Matejka. 1993. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. Am. J. Physiol. 265:C122-C128[Abstract/Free Full Text].
29. Jiang, H., J. Q. Luo, T. Urano, P. Frankel, Z. Lu, D. A. Foster, and L. A. Feig. 1995. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378:409-412[CrossRef][Medline].
30. Jones, D., C. Morgan, and S. Cockcroft. 1999. Phospholipase D and membrane traffic: potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim. Biophys. Acta 1439:229-244[Medline].
31. Jullien-Flores, V., O. Dorseuil, F. Romero, F. Letourneur, S. Saragosti, R. Berger, A. Tavitian, G. Gacon, and J. H. Camonis. 1995. Bridging Ral GTPase to Rho pathways. J. Biol. Chem. 270:22473-22477[Abstract/Free Full Text].
32. Kaziro, Y., H. Itoh, T. Kozasa, M. Nakafuku, and T. Satoh. 1991. Structure and function of signal-transducing GTP-binding proteins. Annu. Rev. Biochem. 60:340-400.
33. Khwaja, A., K. Lehmann, B. M. Marte, and J. Downward. 1998. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem. 273:18793-18801[Abstract/Free Full Text].
34. Kundra, V., B. Anand-Apte, L. A. Feig, and B. R. Zetter. 1995. The chemotactic response to PDGF-BB: evidence of a role for Ras. J. Cell Biol. 130:725-731[Abstract/Free Full Text].
35. Kundra, V., J. A. Escobedo, A. Kazlauskas, H. K. Kim, S. G. Rhee, L. T. Williams, and B. R. Zetter. 1994. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta . Nature 367:474-476[CrossRef][Medline].
36. Lassar, A. B., and A. E. Münsterberg. 1996. The role of positive and negative signals in somite patterning. Curr. Opin. Neurobiol. 6:57-63[CrossRef][Medline].
37. Lawson, M. A., and F. R. Maxfield. 1995. Ca2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 377:75-79[CrossRef][Medline].
38. Lee, K. K. H., C. C. Wong, S. E. Webb, M. K. Tang, A. K. C. Leung, P. F. Kwok, D. Q. Cai, and K. M. Chan. 1999. Hepatocyte growth factor stimulates chemotactic response in mouse embryonic limb myogenic cells in vitro. J. Exp. Zool. 283:170-180[CrossRef][Medline].
39. Lee, T., L. A. Feig, and D. J. Montell. 1996. Two distinct roles for Ras in a developmentally regulated cell migration. Development 122:409-418[Abstract].
40. Lefaucheur, J. P., and A. Sébille. 1995. Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor or insulin-like growth factor I. J. Neuroimmunol. 57:85-91[CrossRef][Medline].
41. Lefaucheur, J. P., and A. Sébille. 1995. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy. Neurosci. Lett. 202:121-124[CrossRef][Medline].
42. Li, S., and K. Muneoka. 1999. Cell migration and chick limb development: chemotactic action of FGF-4 and the AER. Dev. Biol. 211:335-347[CrossRef][Medline].
43. MacGregor, J., and W. S. Parkhouse. 1996. The potential role of insulin-like growth factors in skeletal muscle regeneration. Can. J. Appl. Physiol. 21:236-250[Medline].
44. Martin, G. R. 1998. The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 12:1571-1586[Free Full Text].
45. Matsubara, K., S. Kishida, Y. Matsuura, H. Kitayama, M. Noda, and A. Kikuchi. 1999. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. Oncogene 18:1303-1312[CrossRef][Medline].
46. McNeil, P. L., M. P. McKenna, and D. L. Taylor. 1985. A transient rise in cytosolic calcium follows stimulation of quiescent cells with growth factors and is inhibitable with phorbol myristate acetate. J. Cell Biol. 101:372-379[Abstract/Free Full Text].
47. Mine, T., I. Kojima, E. Ogata, and T. Nakamura. 1991. Comparison of effects of HGF and EGF on cellular calcium in rat hepatocytes. Biochem. Biophys. Res. Commun. 181:1173-1180[CrossRef][Medline].
48. Molkentin, J. D., and E. N. Olson. 1996. Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6:445-453[CrossRef][Medline].
49. M'Rabet, L., P. J. Coffer, R. M. F. Wolthuis, F. Zwartkruis, L. Koenderman, and J. L. Bos. 1999. Differential fMet-Leu-Phe- and platelet-activating factor-induced signaling toward Ral activation in primary human neutrophils. J. Biol. Chem. 274:21847-21852[Abstract/Free Full Text].
50. Nakashima, S., K. Morinaka, S. Koyama, M. Ikeda, M. Kishida, K. Okawa, A. Iwamatsu, S. Kishida, and A. Kikuchi. 1999. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 18:3629-3642[CrossRef][Medline].
51. Ohta, Y., N. Suzuki, S. Nakamura, J. H. Hartwig, and T. P. Stossel. 1999. The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. USA 96:2122-2128[Abstract/Free Full Text].
52. Ohuchi, H., and S. Noji. 1999. Fibroblast-growth-factor-induced additional limbs in the study of initiation of limb formation, limb identity, myogenesis, and innervation. Cell Tissue Res. 296:45-56[CrossRef][Medline].
53. Olson, E. N. 1992. Proto-oncogenes in the regulatory circuit for myogenesis. Semin. Cell Biol. 3:127-136[Medline].
54. Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:261-272[CrossRef][Medline].
55. Ordahl, C. P., and N. Le Douarin. 1992. Two myogenic lineages within the developing somite. Development 114:339-353[Abstract].
56. Park, S. H., and R. A. Weinberg. 1995. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 11:2349-2355[Medline].
57. Potempa, S., and A. J. Ridley. 1998. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell 9:2185-2200[Abstract/Free Full Text].
58. Quaroni, A., and E. C. A. Paul. 1999. Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus. J. Cell Sci. 112:707-718[Abstract].
59. Reichman-Fried, M., B. Dickson, E. Hafen, and B. Z. Shilo. 1994. Elucidation of the role of breathless, a Drosophila FGF receptor homolog, in tracheal cell migration. Genes Dev. 8:428-439[Abstract/Free Full Text].
60. Ridley, A. J., P. M. Comoglio, and A. Hall. 1995. Regulation of scatter factor/hepatocyte growth factor response by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15:1110-1122[Abstract].
61. Royal, I., and M. Park. 1995. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem. 270:27780-27787[Abstract/Free Full Text].
62. Sosnowski, R. G., S. Feldman, and J. R. Feramisco. 1993. Interference with endogenous ras function inhibits cellular responses to wounding. J. Cell Biol. 121:113-119[Abstract/Free Full Text].
63. Stockdale, F. E. 1992. Myogenic cell lineages. Dev. Biol. 154:284-298[CrossRef][Medline].
64. Streck, R. D., T. L. Wood, M. S. Hsu, and J. E. Pintar. 1992. Insulin-like growth factor-I and -II and insulin-like growth factor binding protein-2 RNA are expressed in adjacent tissues within rat embryonic and fetal limbs. Dev. Biol. 151:586-596[CrossRef][Medline].
65. Sundaram, M., J. Yochem, and M. Han. 1996. A Ras-mediated signal transduction pathway is involved in the control of sex myoblast migration in Caenorhabditis elegans. Development 122:2823-2833[Abstract].
66. Terada, K., Y. Kaziro, and T. Satoh. 1995. Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3. J. Biol. Chem. 270:27880-27886[Abstract/Free Full Text].
67. Tsuda, T., K. Kaibuchi, Y. Kawahara, H. Fukuzaki, and Y. Takai. 1985. Induction of protein kinase C activation and Ca2+ mobilization by fibroblast growth factor in Swiss 3T3 cells. FEBS Lett. 191:205-210[CrossRef][Medline].
68. Tuxworth, R. I., J. L. Cheetham, L. M. Machesky, G. B. Spiegelmann, G. Weeks, and R. H. Insall. 1997. Dictyostelium RasG is required for normal motility and cytokinesis, but not growth. J. Cell Biol. 138:605-614[Abstract/Free Full Text].
69. Vojtek, A. B., and C. J. Der. 1998. Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273:19925-19928[Free Full Text].
70. Wang, K. L., and B. D. Roufogalis. 1999. Ca2+/calmodulin stimulates GTP binding to the Ras-related protein Ral-A. J. Biol. Chem. 274:14525-14528[Abstract/Free Full Text].
71. Watt, D. J., J. Karasinski, J. Moss, and M. A. England. 1994. Migration of muscle cells. Nature 368:406-407[CrossRef][Medline].
72. Webb, S. E., K. K. H. Lee, M. K. Tang, and D. A. Ede. 1997. Fibroblast growth factors 2 and 4 stimulate migration of mouse embryonic limb myogenic cells. Dev. Dyn. 209:206-216[CrossRef][Medline].
73. Wennström, S., A. Siegbahn, K. Yokote, A. K. Arvidsson, C. H. Heldin, S. Mori, and L. Claesson-Welsh. 1994. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase. Oncogene 9:651-660[Medline].
74. White, M. A., T. Vale, J. H. Camonis, E. Schaefer, and M. H. Wigler. 1996. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271:16439-16442[Abstract/Free Full Text].
75. Wolthuis, R. M. F., and J. L. Bos. 1998. Ras caught in another affair: the exchange factors for Ral. Curr. Opin. Genet. Dev. 9:112-117.
76. Wolthuis, R. M. F., B. Franke, M. van Triest, B. Bauer, R. H. Cool, J. H. Camonis, J. W. N. Akkerman, and J. L. Bos. 1998. Activation of the small GTPase Ral in platelets. Mol. Cell. Biol. 18:2486-2491[Abstract/Free Full Text].
77. Wolthuis, R. M. F., F. Zwartkruis, T. C. Moen, and J. L. Bos. 1998. Ras-dependent activation of the small GTPase Ral. Curr. Biol. 8:471-474[CrossRef][Medline].
78. Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725-727[CrossRef][Medline].
79. Zigmond, S. H., and J. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis: new methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137:387-410[Abstract].
80. Zwartkruis, F. J. T., R. M. F. Wolthuis, N. M. J. M. Nabben, B. Franke, and J. L. Bos. 1998. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J. 17:5905-5912[CrossRef][Medline].

Molecular and Cellular Biology, July 2000, p. 4658-4665, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Spiczka, K. S., Yeaman, C. (2008). Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration. J. Cell Sci. 121: 2880-2891 [Abstract] [Full Text]  
  • Cruz-Munoz, W., Man, S., Xu, P., Kerbel, R. S. (2008). Development of a Preclinical Model of Spontaneous Human Melanoma Central Nervous System Metastasis. Cancer Res. 68: 4500-4505 [Abstract] [Full Text]  
  • de Gorter, D. J. J., Reijmers, R. M., Beuling, E. A., Naber, H. P. H., Kuil, A., Kersten, M. J., Pals, S. T., Spaargaren, M. (2008). The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells. Blood 111: 3364-3372 [Abstract] [Full Text]  
  • Bae, G.-U., Gaio, U., Yang, Y.-J., Lee, H.-J., Kang, J.-S., Krauss, R. S. (2008). Regulation of Myoblast Motility and Fusion by the CXCR4-associated Sialomucin, CD164. J. Biol. Chem. 283: 8301-8309 [Abstract] [Full Text]  
  • Bondesen, B. A., Jones, K. A., Glasgow, W. C., Pavlath, G. K. (2007). Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion. FASEB J. 21: 3338-3345 [Abstract] [Full Text]  
  • Crepaldi, T., Bersani, F., Scuoppo, C., Accornero, P., Prunotto, C., Taulli, R., Forni, P. E., Leo, C., Chiarle, R., Griffiths, J., Glass, D. J., Ponzetto, C. (2007). Conditional Activation of MET in Differentiated Skeletal Muscle Induces Atrophy. J. Biol. Chem. 282: 6812-6822 [Abstract] [Full Text]  
  • Yoshizaki, H., Mochizuki, N., Gotoh, Y., Matsuda, M. (2007). Akt-PDK1 Complex Mediates Epidermal Growth Factor-induced Membrane Protrusion through Ral Activation. Mol. Biol. Cell 18: 119-128 [Abstract] [Full Text]  
  • Salem, M., Kenney, P. B., Rexroad, C. E. 3rd, Yao, J. (2006). Microarray gene expression analysis in atrophying rainbow trout muscle: a unique nonmammalian muscle degradation model. Physiol. Genomics 28: 33-45 [Abstract] [Full Text]  
  • Jansen, K. M., Pavlath, G. K. (2006). Mannose receptor regulates myoblast motility and muscle growth. JCB 174: 403-413 [Abstract] [Full Text]  
  • Blanke, S., Jackle, H. (2006). Novel guanine nucleotide exchange factor GEFmeso of Drosophila melanogaster interacts with Ral and Rho GTPase Cdc42. FASEB J. 20: 683-691 [Abstract] [Full Text]  
  • Rosse, C., Hatzoglou, A., Parrini, M.-C., White, M. A., Chavrier, P., Camonis, J. (2006). RalB Mobilizes the Exocyst To Drive Cell Migration. Mol. Cell. Biol. 26: 727-734 [Abstract] [Full Text]  
  • Klaile, E., Muller, M. M., Kannicht, C., Singer, B. B., Lucka, L. (2005). CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration. J. Cell Sci. 118: 5513-5524 [Abstract] [Full Text]  
  • Oxford, G., Owens, C. R., Titus, B. J., Foreman, T. L., Herlevsen, M. C., Smith, S. C., Theodorescu, D. (2005). RalA and RalB: Antagonistic Relatives in Cancer Cell Migration. Cancer Res. 65: 7111-7120 [Abstract] [Full Text]  
  • Fuhler, G. M., Knol, G. J., Drayer, A. L., Vellenga, E. (2005). Impaired interleukin-8- and GRO{alpha}-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia. J. Leukoc. Biol. 77: 257-266 [Abstract] [Full Text]  
  • Jimenez, M., de Castro, I. P., Benet, M., Garcia, J. F., Inghirami, G., Pellicer, A. (2004). The Rgr Oncogene Induces Tumorigenesis in Transgenic Mice. Cancer Res. 64: 6041-6049 [Abstract] [Full Text]  
  • Agapova, L. S., Volodina, J. L., Chumakov, P. M., Kopnin, B. P. (2004). Activation of Ras-Ral Pathway Attenuates p53-independent DNA Damage G2 Checkpoint. J. Biol. Chem. 279: 36382-36389 [Abstract] [Full Text]  
  • Wessels, D., Brincks, R., Kuhl, S., Stepanovic, V., Daniels, K. J., Weeks, G., Lim, C. J., Spiegelman, G., Fuller, D., Iranfar, N., Loomis, W. F., Soll, D. R. (2004). RasC Plays a Role in Transduction of Temporal Gradient Information in the Cyclic-AMP Wave of Dictyostelium discoideum. Eukaryot Cell 3: 646-662 [Abstract] [Full Text]  
  • Takaya, A., Ohba, Y., Kurokawa, K., Matsuda, M. (2004). RalA Activation at Nascent Lamellipodia of Epidermal Growth Factor-stimulated Cos7 Cells and Migrating Madin-Darby Canine Kidney Cells. Mol. Biol. Cell 15: 2549-2557 [Abstract] [Full Text]  
  • CHARGE, S. B. P., RUDNICKI, M. A. (2004). Cellular and Molecular Regulation of Muscle Regeneration. Physiol. Rev. 84: 209-238 [Abstract] [Full Text]  
  • Lebreton, S., Boissel, L., Moreau, J. (2003). Control of embryonic Xenopus morphogenesis by a Ral-GDS/Xral branch of the Ras signalling pathway. J. Cell Sci. 116: 4651-4662 [Abstract] [Full Text]  
  • Neuhaus, P., Oustanina, S., Loch, T., Kruger, M., Bober, E., Dono, R., Zeller, R., Braun, T. (2003). Reduced Mobility of Fibroblast Growth Factor (FGF)-Deficient Myoblasts Might Contribute to Dystrophic Changes in the Musculature of FGF2/FGF6/mdx Triple-Mutant Mice. Mol. Cell. Biol. 23: 6037-6048 [Abstract] [Full Text]  
  • Hu, Y., Mivechi, N. F. (2003). HSF-1 Interacts with Ral-binding Protein 1 in a Stress-responsive, Multiprotein Complex with HSP90 in Vivo. J. Biol. Chem. 278: 17299-17306 [Abstract] [Full Text]  
  • Mirey, G., Balakireva, M., L'Hoste, S., Rosse, C., Voegeling, S., Camonis, J. (2003). A Ral Guanine Exchange Factor-Ral Pathway Is Conserved in Drosophila melanogaster and Sheds New Light on the Connectivity of the Ral, Ras, and Rap Pathways. Mol. Cell. Biol. 23: 1112-1124 [Abstract] [Full Text]  
  • Zhu, T., Ling, L., Lobie, P. E. (2002). Identification of a JAK2-independent Pathway Regulating Growth Hormone (GH)-stimulated p44/42 Mitogen-activated Protein Kinase Activity. GH ACTIVATION OF Ral AND PHOSPHOLIPASE D IS Src-DEPENDENT. J. Biol. Chem. 277: 45592-45603 [Abstract] [Full Text]  
  • Oshiro, T., Koyama, S., Sugiyama, S., Kondo, A., Onodera, Y., Asahara, T., Sabe, H., Kikuchi, A. (2002). Interaction of POB1, a Downstream Molecule of Small G Protein Ral, with PAG2, a Paxillin-binding Protein, Is Involved in Cell Migration. J. Biol. Chem. 277: 38618-38626 [Abstract] [Full Text]  
  • Clough, R. R., Sidhu, R. S., Bhullar, R. P. (2002). Calmodulin Binds RalA and RalB and Is Required for the Thrombin-induced Activation of Ral in Human Platelets. J. Biol. Chem. 277: 28972-28980 [Abstract] [Full Text]  
  • Weber, K. S.C., Ostermann, G., Zernecke, A., Schroder, A., Klickstein, L. B., Weber, C. (2001). Dual Role of H-Ras in Regulation of Lymphocyte Function Antigen-1 Activity by Stromal Cell-derived Factor-1alpha : Implications for Leukocyte Transmigration. Mol. Biol. Cell 12: 3074-3086 [Abstract] [Full Text]  
  • Sattler, M., Verma, S., Pride, Y. B., Salgia, R., Rohrschneider, L. R., Griffin, J. D. (2001). SHIP1, an SH2 Domain Containing Polyinositol-5-phosphatase, Regulates Migration through Two Critical Tyrosine Residues and Forms a Novel Signaling Complex with DOK1 and CRKL. J. Biol. Chem. 276: 2451-2458 [Abstract] [Full Text]  
  • Irani, C., Goncharova, E. A., Hunter, D. S., Walker, C. L., Panettieri, R. A., Krymskaya, V. P. (2002). Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L854-L862 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, J.
Right arrow Articles by Koide, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, J.
Right arrow Articles by Koide, H.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»